LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $687 | -5.4% | 11,185 | +11.8% | 0.00% | 0.0% |
| Q2 2023 | $726 | +2.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $708 | +5.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $670 | -99.9% | 10,000 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $847,000 | +114.4% | 10,000 | +120.3% | 0.00% | +200.0% |
| Q2 2022 | $395,000 | -25.0% | 4,540 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $527,000 | -21.2% | 4,540 | +9.7% | 0.00% | -50.0% |
| Q4 2021 | $669,000 | +18.8% | 4,140 | +2.5% | 0.00% | 0.0% |
| Q3 2021 | $563,000 | +4.5% | 4,040 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $539,000 | -9.9% | 4,040 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $598,000 | +51.0% | 4,040 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $396,000 | -1.0% | 4,040 | -4.7% | 0.00% | -50.0% |
| Q3 2020 | $400,000 | -50.1% | 4,240 | -47.6% | 0.00% | -60.0% |
| Q3 2019 | $801,000 | -57.9% | 8,090 | -51.5% | 0.01% | -50.0% |
| Q2 2019 | $1,902,000 | -20.9% | 16,680 | +78.6% | 0.01% | -28.6% |
| Q1 2019 | $2,406,000 | +110.7% | 9,340 | +12.0% | 0.01% | +75.0% |
| Q4 2018 | $1,142,000 | -52.5% | 8,340 | -10.7% | 0.01% | -42.9% |
| Q3 2018 | $2,406,000 | +20.8% | 9,340 | -2.5% | 0.01% | +7.7% |
| Q2 2018 | $1,992,000 | +28.4% | 9,580 | 0.0% | 0.01% | +18.2% |
| Q1 2018 | $1,552,000 | +24.6% | 9,580 | -1.9% | 0.01% | +10.0% |
| Q4 2017 | $1,246,000 | 0.0% | 9,770 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $1,246,000 | +5.1% | 9,770 | 0.0% | 0.01% | +11.1% |
| Q2 2017 | $1,186,000 | +15.4% | 9,770 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $1,028,000 | -4.3% | 9,770 | -7.4% | 0.01% | -18.2% |
| Q4 2016 | $1,074,000 | +7.9% | 10,550 | +8.2% | 0.01% | 0.0% |
| Q3 2016 | $995,000 | -16.0% | 9,750 | 0.0% | 0.01% | -15.4% |
| Q2 2016 | $1,184,000 | +18.8% | 9,750 | +2.6% | 0.01% | +8.3% |
| Q1 2016 | $997,000 | -8.8% | 9,500 | -5.9% | 0.01% | -7.7% |
| Q4 2015 | $1,093,000 | +28.9% | 10,100 | +2.0% | 0.01% | +30.0% |
| Q3 2015 | $848,000 | -12.0% | 9,900 | +3.7% | 0.01% | -9.1% |
| Q2 2015 | $964,000 | +36.0% | 9,550 | +3.8% | 0.01% | +22.2% |
| Q1 2015 | $709,000 | +21.8% | 9,200 | -17.5% | 0.01% | +28.6% |
| Q4 2014 | $582,000 | +1.9% | 11,150 | -8.2% | 0.01% | -12.5% |
| Q3 2014 | $571,000 | -22.6% | 12,150 | +2.5% | 0.01% | -27.3% |
| Q2 2014 | $738,000 | -9.3% | 11,850 | -2.1% | 0.01% | -15.4% |
| Q1 2014 | $814,000 | +30.7% | 12,100 | +4.3% | 0.01% | +30.0% |
| Q4 2013 | $623,000 | +27.4% | 11,600 | +2.7% | 0.01% | +11.1% |
| Q3 2013 | $489,000 | – | 11,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |